Scott Tagawa, MD, and Valentina Marulanda Corzo, MD, of Weill Cornell Medicine, discuss their work on a study presented at the SNMMI 2025 Annual Meeting that examined the use of single time-point SPECT/CT dosimetry for 177Lu-PSMA targeted radionuclide therapy in patients with mCRPC.
Dr. Marulanda Corzo describes the two different time points that were studied, as well as how future research should be focused on precision medicine and personalized therapy.